You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematopoietic malignancies

Showing 1 - 25 of 4,906
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Hematological Malignancy Trial (Thymoglobulin Injectable Product)

Not yet recruiting
  • Hematological Malignancy
  • Thymoglobulin Injectable Product
  • (no location specified)
Sep 27, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

Not yet recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023

Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

Recruiting
  • Hematologic Malignancies
  • Haplo HCT <55 years old
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 25, 2023

Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

Recruiting
  • Myeloid Malignancies
  • fractionated busulfan-based conditioning regimen
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Mar 29, 2023

Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

Suspended
  • Hematologic Neoplasms
  • donor lymphocyte infusion
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 30, 2022

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS Trial in Washington, Baltimore (Tumor associated

Recruiting
  • Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
  • Tumor associated antigen lymphocytes (TAA-T)
  • Washington, District of Columbia
  • +1 more
Jul 15, 2021

Myeloid Diseases Trial in Middletown, New York (drug, radiation, procedure)

Recruiting
  • Myeloid Diseases
  • Antithymocyte globulin (Rabbit)
  • +5 more
  • Middletown, New Jersey
  • +1 more
Jan 19, 2023

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

Not yet recruiting
  • Hematologic Malignancy
  • +5 more
  • autologous hematopoietic stem cells added to planned CAR T
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 31, 2023

Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Hematological Malignancy
  • Ningbo, Zhejiang, China
    The Affiliated People's Hospital of Ningbo University.
Aug 18, 2022

Pediatric Hematologic Malignancies Trial in Saint Louis (Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs

Not yet recruiting
  • Pediatric Hematologic Malignancies
  • Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs Plus
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 20, 2022

Allogenic Stem Cell Transplantation Trial (SAR445419)

Not yet recruiting
  • Allogenic Stem Cell Transplantation
  • (no location specified)
Feb 13, 2023

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Duarte (Cholestyramine, Leflunomide, Steroid Therapy)

Recruiting
  • Acute Graft Versus Host Disease
  • Hematopoietic and Lymphoid System Neoplasm
  • Duarte, California
    City of Hope Medical Center
Jan 5, 2023

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Patient Fitness and Body Composition During Hematopoietic Stem

    Active, not recruiting
    • Hematologic Malignancy
    • Observational
    • Seattle, Washington
      VA Puget Sound Health Care System
    Aug 2, 2022

    Acute Myeloid Leukemia (AML), B-cell Non-Hodgkin's Lymphoma (B-NHL), Multiple Myeloma (MM) Trial in Shanghai (Autologous CAR-T

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +4 more
    • Autologous CAR-T cells
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Pudong Hospital, Fudan University Affiliated Pudong Med
    Aug 22, 2022

    Hematopoietic and Lymphoid Cell Tumor Trial in Seattle (Nutritional Supplement Drink, Standard of Care Nutritional Support,

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Nutritional Supplement Drink
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 8, 2022

    Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Total-Body Irradiation
    • +5 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Sep 7, 2022

    Myelodysplasia, Hematologic Malignancy Trial in Columbus (CliniMACS® TCRaß/CD19 Combined Depletion System)

    Recruiting
    • Myelodysplasia
    • Hematologic Malignancy
    • CliniMACS® TCRαβ/CD19 Combined Depletion System
    • Columbus, Ohio
      Nationwide Children's Hospital
    Jan 11, 2022

    Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

    Recruiting
    • Hematologic Malignancy
    • Myeloid Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Nov 7, 2022

    AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

    Not yet recruiting
    • AML
    • +5 more
    • Infusion of CD34 selected hematopoietic stem cells
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 14, 2023

    B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Non-Interventional Study
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 22, 2023